Sites
- ahajournals.org
- bmj.com
- drugs.com
- eurekalert.org
- fda.gov
- healthline.com
- mayoclinic.org
- mayoclinicproceedings.org
- medscape.com
- nih.gov
- rxlist.com
- sciencedaily.com
- web.archive.org
- webmd.com
- wikipedia.org
Tags
- A
- ABCA1
- Ace inhibitor
- Acetylcholinesterase inhibitor
- Acetyl-CoA
- Acute tubular necrosis
- Acyl-CoA
- Addiction medicine
- Akira Endo
- Alkylating antineoplastic agent
- Alternative medicine
- American College of Cardiology
- American Heart Association
- Amlodipine
- Anabolic steroid
- Analgesic
- Anesthetic
- Angina
- Angiotensin II receptor antagonist
- ANGPTL3
- Ankle–brachial pressure index
- Anorectic
- Antacid
- Anthelmintic
- Antiarrhythmic agent
- Antibacterial
- Anticoagulant
- Anticonvulsant
- Antidepressant
- Anti-diabetic medication
- Antidote
- Antiemetic
- Antifungal
- Antihemorrhagic
- Antihypertensive drug
- Anti-inflammatory
- Antimicrobial
- Antimigraine drug
- Anti-obesity medication
- Antiparasitic
- Antiplatelet drug
- Antiprotozoal
- Antipruritic
- Antipsychotic
- Antithrombotic
- Antithyroid agent
- Antiviral drug
- Anxiolytic
- Aortic aneurysm
- Aphrodisiac
- APOA2
- APOA5
- Apolipoprotein B
- Apolipoprotein C3
- Apolipoprotein E
- Arachidonate 5-lipoxygenase inhibitor
- Archaea
- Aromatase inhibitor
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Aspergillus
- Atheroma
- Atherosclerosis
- Atorvastatin
- ATP citrate lyase
- Attention deficit hyperactivity disorder
- Benfluorex
- Bergamottin
- Beta blocker
- Bezafibrate
- Bibcode
- Bile acid sequestrant
- Biological target
- Bisphosphonate
- Bitter orange
- Bladder cancer
- Blood
- Blood vessel
- Bone
- Breast cancer
- Bristol-Myers Squibb
- Bronchodilator
- Calcium channel blocker
- Cardiac Arrest
- Cardiac glycoside
- Cardiac stimulant
- Cardiology
- Cardiovascular disease
- Cataract
- Cell membrane
- Cell nucleus
- Cerivastatin
- Chemical synthesis
- Chemotherapy
- Cholesterol
- Cholesterol-lowering
- Cholesterylester transfer protein
- Cholic acid
- Cicatrizant
- Ciclosporin
- Circulation
- Circulatory System
- Cleveland Clinic
- Clinical trial
- Clofibrate
- Coagulation
- Cochrane
- Cochrane Library
- Coenzyme Q10
- Colesevelam
- Colestipol
- Colestyramine
- Colorectal cancer
- Competitive inhibition
- COMT inhibitor
- Consumer Reports
- Contrast medium
- Cookies Lower
- Coronary artery disease
- Coronary catheterization
- Corticosteroid
- Cough medicine
- COVID-19
- COX-2 inhibitor
- C-reactive protein
- Current Atherosclerosis Reports
- CYP2C19
- CYP2C8
- CYP2C9
- CYP3A
- CYP3A4
- Cytochrome P450
- Cytoskeleton
- Daiichi Sankyo
- Decongestant
- Deliriant
- Dementia
- Depressant
- Diabetes
- Diabetes mellitus
- Diet
- Dietary fiber
- Diglyceride
- Dipeptidyl peptidase-4 inhibitor
- Disease
- Disease-modifying antirheumatic drug
- Dissociative
- Diuretic
- DOI
- Dressing
- Drug
- Drug class
- Dyslipidemia
- Effect
- Elevated transaminases
- Empathogen–entactogen
- Endocrine system
- Endothelium
- Entheogen
- Enzyme
- Enzyme inhibitor
- Esophageal cancer
- Eukaryote
- Euphoria
- European Society of Cardiology
- Evinacumab
- Evolocumab
- Ezetimibe
- Familial hypercholesterolemia
- Farnesyl pyrophosphate
- Fatty acid
- Fenofibrate
- Fermentation
- Fertility medication
- Fibrate
- Fluvastatin
- Food and Drug Administration
- Fortune
- Gastrointestinal tract
- General anaesthetic
- Generic drug
- Genitourinary system
- George Davey Smith
- Geranylgeranyl pyrophosphate
- Glucocorticoid
- Glucomannan
- GLUT1
- Grapefruit
- Grapefruit–drug interactions
- Grapefruit juice
- GW501516
- H1 antagonist
- H2 antagonist
- Half-life
- Hallucinogen
- Harriet A. Hall
- HDL
- Heart
- Heart attack
- Heart health
- Hepatocellular carcinoma
- Hepatocyte
- Hepatotoxicity
- High-density lipoprotein
- Histone deacetylase inhibitor
- HIV-positive people
- HMG-CoA
- HMG-CoA reductase
- Hormonal contraception
- Hormone
- Human brain
- Human skin
- Hydrolase
- Hypercholesterolemia
- Hyperlipidemia
- Hypertension
- Hypnotic
- Hypocholesterolemia
- Hypothyroidism
- Immune system
- Immunoglobulin therapy
- Immunostimulant
- Immunosuppressive drug
- Immunotherapy
- Imperial College School of Medicine
- Infection
- Inflammation
- Insulin
- Intermediate-density lipoprotein
- International Standard Book Number
- International Standard Serial Number
- Intracerebral hemorrhage
- Intravascular ultrasound
- Ion-exchange resin
- Irritable bowel syndrome
- Ischemia
- JAMA
- Janus kinase inhibitor
- Japan Prize
- Joint
- Joseph L. Goldstein
- Journal of the American College of Cardiology
- JUPITER trial
- Kidney cancer
- Kidney failure
- Kidney transplantation
- Lasker-DeBakey Clinical Medical Research Award
- Laxative
- LDL
- LDL receptor
- Lipid hypothesis
- Lipid-lowering agent
- Lipoprotein lipase
- Liver
- Liver function tests
- Local anesthetic
- London
- Lovastatin
- Low-density lipoprotein
- Lower cholesterol
- Low-fat diet
- LRP1
- Lung cancer
- Lyase
- Malignant
- Mayo Clinic
- Medical guideline
- Medical Subject Headings
- Merck & Co.
- Meta-analysis
- Metabolism
- Mevalonate pathway
- Mevastatin
- Michael Stuart Brown
- Microsomal triglyceride transfer protein
- Mineral
- Mineralocorticoid
- Moisturizer
- Monoamine oxidase inhibitor
- Mood stabilizer
- Multiple sclerosis
- Muscle
- Muscle relaxant
- Myalgia
- Myocardial infarction
- Myopathy
- National Heart, Lung, and Blood Institute
- National Institute for Health and Care Excellence
- National Institutes of Health
- National Inventors Hall of Fame
- Nervous system
- Neuraminidase inhibitor
- Neuropathy
- Neuroprotection
- Neurotoxin
- New research
- New York Times
- Niacin
- Nocebo
- Non-competitive inhibition
- Nonsteroidal anti-inflammatory drug
- Nootropic
- NPC1L1
- Omega-3 fatty acid
- Ophthalmology
- Orexigenic
- Otology
- Oxidoreductase
- Ozempic
- Pancreas
- Pancreatic cancer
- PARP inhibitor
- Patient
- PCSK9
- Penicillium
- Penicillium citrinum
- Perindopril
- Pfizer
- Pharmaceutical Press
- Pharmacological Research
- Pharmacology
- Phases of clinical research
- Phosphodiesterase inhibitor
- Phospholipid
- Physical exercise
- Pitavastatin
- Platelet
- Pleiotropy
- Pleurotus ostreatus
- PMC
- Pneumonia
- Policosanol
- PPAR agonist
- Pravastatin
- Prenylation
- Preventive healthcare
- Prostate cancer
- Protease
- Protease inhibitor
- Protein Data Bank
- Protein kinase inhibitor
- Proton-pump inhibitor
- P. Roy Vagelos
- Pseudoscience
- Psoriasis
- Psychedelic drug
- Psyllium
- PubMed
- Radiopharmacology
- Randomized controlled trial
- Red yeast rice
- Releasing and inhibiting hormones
- Renal function
- Renin–angiotensin system
- Respiratory system
- Reverse-transcriptase inhibitor
- Rhabdomyolysis
- Risk factor
- Rosuvastatin
- Secondary metabolite
- Sedative
- Serenic
- Sex steroid
- Sexual dysfunction
- Simvastatin
- Skeletal muscle
- Smoking
- Squalene
- Squalene monooxygenase
- Statine
- Steven Nissen
- Stimulant
- Stomach cancer
- Stroke
- Suicide inhibition
- Synonym
- Terpenoid
- The guardian
- The Lancet
- The Wall Street Journal
- Thrombolysis
- Thrombosis
- Thyroid hormones
- Transferase
- Triglyceride
- Trypsin inhibitor
- Tyrosine-kinase inhibitor
- United States National Library of Medicine
- United States Preventive Services Task Force
- Vaccine
- Vasodilation
- Very low-density lipoprotein
- Vitamin
- Wakefulness-promoting agent
- Warfarin
- Wayback Machine
- What
- WHO Model List of Essential Medicines
- World Health Organization
- Xanthine oxidase inhibitor
- Zygosity